AMPE Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.

$0.07  +0.00 (2.57%)
As of 09/27/2022 10:57:10 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/18/2011
Outstanding shares:  226,286,867
Average volume:  11,405,589
Market cap:   $17,016,772
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B5BNLD2
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.77
PS ratio:   0.00
Return on equity:   -85.58%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy